The medication known as EPIDIOLEX has shown promising market potential as there is a rising demand for alternative therapies. It has been proven effective in treating rare seizure disorders such as Lennox-Gastaut syndrome and Dravet syndrome. The increasing awareness of the benefits of CBD in managing neurological conditions is contributing to the popularity of EPIDIOLEX. This medication has the potential to address the needs of a considerable number of patients who are seeking solutions for these debilitating disorders.